EGFR and non-small cell lung carcinoma: While one study showed that an elevated NLR ≥ 3.5 was associated with poor outcomes in EGFR-mutated advanced NSCLC [15], another has shown that NLR did not affect survival in EGFR-mutated advanced NSCLC [21].